Rhythm Pharmaceuticals Inc. (RYTM)
Market Closed
16 Oct, 08:00 PM
$
86. 20
-1.77
-2.0166%
$
6.23B Market Cap
- P/E Ratio
- Div Yield
272,192 Volume
-4.17 Eps
$ 87.97
Previous Close 
Want to track RYTM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rhythm Pharmaceuticals Inc. (RYTM) Statistics
Valuation metrics
Market Cap 6.23B
Enterprise value 6.16B
Trailing P/E (ttm) -29.19
Forward P/E -
PEG ratio 7.3
Price/Sales (ttm) 25.95
Price/Book (mrq) 28.66
Enterprise Value/Revenue 25.7
Enterprise Value/EBITDA -33.38
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.41M
Average volume (90 days) 707.8K
Price summary
52-Week low 74.5
52-Week high 122.2
Beta -
50-Day moving average 102.12
200-Day moving average 93.12
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.86%
Operating margin -0.84%
Operational effectiveness
Return on assets -0.47%
Return on equity -0.8%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.5
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.99
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.82
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 3.45%
Book value per share (mrq) 3.17
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
